Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Decreased survival and hepato-renal pathology in mice with C-terminally truncated GP73 (GOLPH2).

Wright LM, Yong S, Picken MM, Rockey D, Fimmel CJ.

Int J Clin Exp Pathol. 2009;2(1):34-47. Epub 2008 Apr 24.

2.

GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus.

Wei S, Dunn TA, Isaacs WB, De Marzo AM, Luo J.

Prostate. 2008 Sep 15;68(13):1387-95. doi: 10.1002/pros.20806.

3.

Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover.

Dong Z, Saliganan AD, Meng H, Nabha SM, Sabbota AL, Sheng S, Bonfil RD, Cher ML.

Neoplasia. 2008 May;10(5):439-49.

4.
5.

Role of the TMPRSS2-ERG gene fusion in prostate cancer.

Tomlins SA, Laxman B, Varambally S, Cao X, Yu J, Helgeson BE, Cao Q, Prensner JR, Rubin MA, Shah RB, Mehra R, Chinnaiyan AM.

Neoplasia. 2008 Feb;10(2):177-88.

6.

A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer.

Laxman B, Morris DS, Yu J, Siddiqui J, Cao J, Mehra R, Lonigro RJ, Tsodikov A, Wei JT, Tomlins SA, Chinnaiyan AM.

Cancer Res. 2008 Feb 1;68(3):645-9. doi: 10.1158/0008-5472.CAN-07-3224.

7.

Common human cancer genes discovered by integrated gene-expression analysis.

Lu Y, Yi Y, Liu P, Wen W, James M, Wang D, You M.

PLoS One. 2007 Nov 7;2(11):e1149.

8.
9.

Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process.

Chandran UR, Ma C, Dhir R, Bisceglia M, Lyons-Weiler M, Liang W, Michalopoulos G, Becich M, Monzon FA.

BMC Cancer. 2007 Apr 12;7:64.

10.

Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model.

Mertz KD, Setlur SR, Dhanasekaran SM, Demichelis F, Perner S, Tomlins S, Tchinda J, Laxman B, Vessella RL, Beroukhim R, Lee C, Chinnaiyan AM, Rubin MA.

Neoplasia. 2007 Mar;9(3):200-6.

11.

Integrative molecular concept modeling of prostate cancer progression.

Tomlins SA, Mehra R, Rhodes DR, Cao X, Wang L, Dhanasekaran SM, Kalyana-Sundaram S, Wei JT, Rubin MA, Pienta KJ, Shah RB, Chinnaiyan AM.

Nat Genet. 2007 Jan;39(1):41-51. Epub 2006 Dec 17.

PMID:
17173048
12.

Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer.

Laxman B, Tomlins SA, Mehra R, Morris DS, Wang L, Helgeson BE, Shah RB, Rubin MA, Wei JT, Chinnaiyan AM.

Neoplasia. 2006 Oct;8(10):885-8.

13.

Inhibition of androgen-independent prostate cancer by estrogenic compounds is associated with increased expression of immune-related genes.

Coleman IM, Kiefer JA, Brown LG, Pitts TE, Nelson PS, Brubaker KD, Vessella RL, Corey E.

Neoplasia. 2006 Oct;8(10):862-78.

14.

Exosomes biological significance: A concise review.

Johnstone RM.

Blood Cells Mol Dis. 2006 Mar-Apr;36(2):315-21. Epub 2006 Feb 17. Review.

PMID:
16487731
15.

Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis.

Mehra R, Varambally S, Ding L, Shen R, Sabel MS, Ghosh D, Chinnaiyan AM, Kleer CG.

Cancer Res. 2005 Dec 15;65(24):11259-64.

16.

Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.

Varambally S, Yu J, Laxman B, Rhodes DR, Mehra R, Tomlins SA, Shah RB, Chandran U, Monzon FA, Becich MJ, Wei JT, Pienta KJ, Ghosh D, Rubin MA, Chinnaiyan AM.

Cancer Cell. 2005 Nov;8(5):393-406.

17.

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM.

Science. 2005 Oct 28;310(5748):644-8.

18.

GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.

Marrero JA, Romano PR, Nikolaeva O, Steel L, Mehta A, Fimmel CJ, Comunale MA, D'Amelio A, Lok AS, Block TM.

J Hepatol. 2005 Dec;43(6):1007-12. Epub 2005 Jun 28.

PMID:
16137783
19.

Phenotypic anchoring of gene expression changes during estrogen-induced uterine growth.

Moggs JG, Tinwell H, Spurway T, Chang HS, Pate I, Lim FL, Moore DJ, Soames A, Stuckey R, Currie R, Zhu T, Kimber I, Ashby J, Orphanides G.

Environ Health Perspect. 2004 Nov;112(16):1589-606.

20.

Prostate cancer detection on urinalysis for alpha methylacyl coenzyme a racemase protein.

Rogers CG, Yan G, Zha S, Gonzalgo ML, Isaacs WB, Luo J, De Marzo AM, Nelson WG, Pavlovich CP.

J Urol. 2004 Oct;172(4 Pt 1):1501-3.

PMID:
15371879

Supplemental Content

Support Center